Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia

Clinical trial NCT07133997 · RECRUITING

Trial details

NCT number

NCT07133997

Sponsor

City of Hope Medical Center

Status

RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2026-05-20

Primary completion

2028-06-01

Enrollment

26

View on ClinicalTrials.gov